Table 3 The significant m6A -SNPs for DBP in GWAS-2018

From: Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure

SNP rsID

Gene

CHR

Positiona

EA

EAF

GWAS

eQTL effect

Confidence level

m6A functionc

β DBP

P DBP

β CAD

P CAD

β stroke

P stroke

Asianb

rs56001051

C1orf167

1

11,838,841

G

0.10

−0.0354

4.50E − 19

Yes

cis

Low

Gain

rs8024

IPO9

1

201,845,575

A

0.32

0.0166

1.62E − 10

0.0416

3.60E − 05

0.0258

7.03E − 03

No

cis

High

Loss

rs2275155

SDCCAG8

1

243,493,907

T

0.33

0.0257

1.06E − 21

No

cis

Low

Loss

rs9847953

ZNF589

3

48,282,695

G

0.23

−0.0152

7.59E −09

−0.0317

1.99E −03

No

cis

Low

Loss

rs1353776

AMOTL2

3

134,077,470

G

0.39

−0.0142

3.14E − 08

−0.0267

7.95E − 03

No

trans

Low

Gain

rs3757138

BTN3A2

6

26,376,103

G

0.11

−0.0199

3.49E − 08

No

cis

High

Loss

rs1978

BTN3A2

6

26,377,573

A

0.11

−0.0200

3.10E − 08

No

cis

Low

Gain

rs853678

ZSCAN31

6

28,297,313

A

0.11

−0.0188

1.48E − 08

0.0258

3.04E − 02

Yes

cis

Medium

Loss

rs2232423

ZSCAN12

6

28,366,151

G

0.08

−0.0243

2.26E − 10

No

trans

Medium

Loss

rs450630

SCAND3

6

28,542,424

A

0.42

−0.0151

9.56E − 10

No

cis

Medium

Loss

rs9262143

PPP1R18

6

30,652,781

T

0.09

−0.0207

2.63E − 09

No

cis

Low

Gain

rs1049633

DDR1

6

30,867,527

A

0.09

−0.0211

8.35E − 10

No

trans

Medium

Loss

rs2233974

C6orf15

6

31,080,016

G

0.15

−0.0195

2.96E − 10

No

trans

Low

Gain

rs707908

HLA-C

6

31,238,053

C

0.39

0.0209

3.80E − 16

No

cis

Low

Loss

rs3115672

MSH5

6

31,727,897

T

0.08

−0.0254

1.94E −12

No

trans

Low

Gain

rs4993986

HLA-DQB1

6

32,627,652

G

0.50

0.0152

3.45E −09

No

trans

High

Loss

rs564449

EPO

7

100,321,138

G

0.11

−0.0240

3.61E − 10

−0.0387

9.45E − 03

No

trans

Low

Gain

rs1733860

PODXL

7

131,185,995

A

0.36

0.0141

1.94E − 08

No

trans

Low

Gain

rs2979247

ERI1

8

8,888,948

G

0.41

0.0173

4.41E − 12

No

cis

Low

Loss

rs4639

NEIL2

8

11,644,751

G

0.41

0.0177

9.98E − 13

No

cis

Low

Gain

rs1801253

ADRB1

10

115,805,056

C

0.34

0.0242

6.04E − 18

No

cis

Low

Loss

rs7398833

CUX2

12

111,786,892

C

0.24

−0.0257

2.00E −18

−0.0344

1.22E −03

−0.0431

1.78E − 05

No

trans

Low

Gain

rs12828755

PITPNM2

12

123,470,586

T

0.22

−0.0201

7.00E − 11

−0.0299

1.14E − 02

No

cis

Low

Gain

rs72681869

SOS2

14

50,655,357

C

0.01

−0.0779

4.97E − 11

−-

No

trans

Low

Gain

rs1885986

SMG6

17

2,203,175

G

0.34

−0.0155

2.06E −09

No

cis

Medium

Gain

rs6066802

PREX1

20

47,261,017

C

0.26

−0.0157

2.04E − 08

0.0293

3.61E − 03

No

cis

Low

Gain

  1. m6A-SNP N6-methyladenosine-associated single-nucleotide polymorphisms, GWAS genome-wide association studies, CAD coronary artery disease, CHR chromosome, DBP diastolic blood pressure, EA effect allele, EAF effect allele frequency, eQTL expression quantitative locus, SBP systolic blood pressure, SE standard error, SNP single-nucleotide polymorphism
  2. aAssembly: GRCh37.p13
  3. bWhether the BP association has been replicated in East Asians
  4. cThe effect alleles may result in loss or gain of m6A sites